Clinicopathological features and prevalence of prostate cancer in Aseer, Saudi Arabia

被引:1
作者
Otifi, Hassan M. [1 ]
Abdul-Wahab, Osama M. S. [3 ]
Al-Shyarba, Mishari H. [2 ]
Al Fayi, Majed S. S. [3 ]
Al Murea, Abdullah H. [4 ]
Yacoub, Elhem [5 ]
机构
[1] Coll Med, Dept Pathol, Abha, Saudi Arabia
[2] Coll Med, Dept Surg, Abha, Saudi Arabia
[3] King Khalid Univ, Fac Appl Med Sci, Dept Clin Lab Sci, Abha, Saudi Arabia
[4] Aseer Cent Hosp, Dept Lab, Abha, Saudi Arabia
[5] Univ Tunis El Manar, Specialized Unit Mycoplasmas, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Inst Pasteur Tunis, Tunis, Tunisia
关键词
prostate cancer; incidence; Aseer region; Saudi Arabia;
D O I
10.15537/smj.2022.43.7.20210758
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine the prevalence and characterize prostate cancer (PC) cases in Aseer, Saudi Arabia. Methods: This study involved 883 patients who consulted physicians in Aseer Central Hospital, Abha, Saudi Arabia, for prostate issues between the years 2008-2018. All patients underwent digital rectal examination and measurement of their serum prostate-specific antigen levels. For patients who presented abnormal digital rectal examination findings and elevated prostate-specific antigen levels, prostate biopsies were recommended. Specimens were histopathologically examined to differentiate between malignant and benign tumors. Results: Among the 883 included patients, 132 (15%) underwent a prostate biopsy and were found to have a tumor. Histopathological examination confirmed malignancy (PC) in 77 (8.7%) patients. The absolute majority of the patients diagnosed with PC (96%) were aged >60 years and almost all of them (92%) were found to have a high prostate-specific antigen level of >4 ng/ml. Conclusion: Prostate cancer appears to be a serious disease in Aseer, Saudi Arabia. Further studies aimed at determining the causes of this type of cancer and understanding its mechanisms are warranted.
引用
收藏
页码:755 / 759
页数:5
相关论文
共 13 条
  • [1] Alghamidi Ibrahim G, 2014, Hematol Oncol Stem Cell Ther, V7, P18, DOI 10.1016/j.hemonc.2013.10.001
  • [2] Yield of prostate cancer screening at a community based clinic in Saudi Arabia
    Almutairi, Abdulaziz A.
    Edali, Abdelmoneim M.
    Khan, Shoaib A.
    Aldihan, Wala A.
    Alkhenizan, Abdullah H.
    [J]. SAUDI MEDICAL JOURNAL, 2019, 40 (07) : 681 - 686
  • [3] American Cancer Society, SCREEN TESTS PROST C
  • [4] International Agency for Research on Cancer, 2020, SAU AR GLOB
  • [5] Diet, nutrition, and cancer risk: what do we know and what is the way forward?
    Key, Timothy J.
    Bradbury, Kathryn E.
    Perez-Cornago, Aurora
    Sinha, Rashmi
    Tsilidis, Konstantinos K.
    Tsugane, Shoichiro
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 368
  • [6] PATTERN OF CANCER AT ASIR-CENTRAL-HOSPITAL, ABHA, SAUDI-ARABIA
    KHAN, AR
    HUSSAIN, NK
    ALSAIGH, A
    MALATANI, T
    SHEIKHA, AA
    [J]. ANNALS OF SAUDI MEDICINE, 1991, 11 (03) : 285 - 288
  • [7] Prostate Cancer in Primary Care
    Merriel, Samuel W. D.
    Funston, Garth
    Hamilton, Willie
    [J]. ADVANCES IN THERAPY, 2018, 35 (09) : 1285 - 1294
  • [8] Cancer treatment and survivorship statistics, 2019
    Miller, Kimberly D.
    Nogueira, Leticia
    Mariotto, Angela B.
    Rowland, Julia H.
    Yabroff, K. Robin
    Alfano, Catherine M.
    Jemal, Ahmedin
    Kramer, Joan L.
    Siegel, Rebecca L.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (05) : 363 - 385
  • [9] Mosli HA, 2003, SAUDI MED J, V24, P573
  • [10] Mosli HA, 2009, SAUDI MED J, V30, P1439